-DOCSTART- -X- O
Porcine -X- _ B-Patient
epidemic -X- _ I-Patient
diarrhea -X- _ I-Patient
virus -X- _ I-Patient
( -X- _ I-Patient
PEDV -X- _ I-Patient
) -X- _ I-Patient
is -X- _ O
a -X- _ O
causative -X- _ O
agent -X- _ O
of -X- _ O
porcine -X- _ O
epidemic -X- _ O
diarrhea -X- _ O
( -X- _ O
PED -X- _ O
) -X- _ O
. -X- _ O
PED -X- _ O
, -X- _ O
characterized -X- _ O
by -X- _ O
acute -X- _ O
diarrhea -X- _ O
, -X- _ O
vomiting -X- _ O
, -X- _ O
dehydration -X- _ O
, -X- _ O
has -X- _ O
caused -X- _ O
serious -X- _ O
economic -X- _ O
losses -X- _ O
in -X- _ O
pig -X- _ O
industry -X- _ O
worldwide. -X- _ O
Here -X- _ O
, -X- _ O
we -X- _ O
demonstrate -X- _ O
that -X- _ O
activation -X- _ O
of -X- _ O
a -X- _ O
disintergrin -X- _ O
and -X- _ O
metalloprotease -X- _ B-Intervention
17 -X- _ I-Intervention
( -X- _ I-Intervention
ADAM17 -X- _ I-Intervention
) -X- _ I-Intervention
induced -X- _ B-Outcome
the -X- _ I-Outcome
decrease -X- _ I-Outcome
of -X- _ I-Outcome
PEDV -X- _ I-Outcome
infection -X- _ I-Outcome
in -X- _ I-Outcome
HEK293 -X- _ I-Outcome
and -X- _ I-Outcome
IPEC-J2 -X- _ I-Outcome
cells -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
downregulation -X- _ I-Outcome
of -X- _ I-Outcome
cell -X- _ I-Outcome
surface -X- _ I-Outcome
aminopeptidase -X- _ I-Outcome
N -X- _ I-Outcome
( -X- _ I-Outcome
APN -X- _ I-Outcome
) -X- _ I-Outcome
expression -X- _ I-Outcome
, -X- _ I-Outcome
an -X- _ I-Outcome
important -X- _ I-Outcome
entry -X- _ I-Outcome
factor -X- _ I-Outcome
for -X- _ I-Outcome
PEDV -X- _ I-Outcome
infection. -X- _ I-Outcome
Furthermore -X- _ O
, -X- _ O
overexpression -X- _ B-Outcome
of -X- _ I-Outcome
ADAM17 -X- _ I-Outcome
suppressed -X- _ I-Outcome
PEDV -X- _ I-Outcome
infection -X- _ I-Outcome
in -X- _ I-Outcome
HEK293 -X- _ I-Outcome
and -X- _ I-Outcome
IPEC-J2 -X- _ I-Outcome
cells -X- _ I-Outcome
, -X- _ I-Outcome
whereas -X- _ I-Outcome
ablation -X- _ I-Outcome
of -X- _ I-Outcome
ADAM17 -X- _ I-Outcome
expression -X- _ I-Outcome
using -X- _ I-Outcome
ADAM17 -X- _ I-Outcome
specific -X- _ I-Outcome
siRNA -X- _ I-Outcome
resulted -X- _ I-Outcome
in -X- _ I-Outcome
a -X- _ I-Outcome
corresponding -X- _ I-Outcome
increase -X- _ I-Outcome
of -X- _ I-Outcome
PEDV -X- _ I-Outcome
infection -X- _ I-Outcome
and -X- _ I-Outcome
an -X- _ I-Outcome
upregulation -X- _ I-Outcome
of -X- _ I-Outcome
cell -X- _ I-Outcome
surface -X- _ I-Outcome
APN -X- _ I-Outcome
expression. -X- _ I-Outcome
Taken -X- _ O
together -X- _ O
, -X- _ O
these -X- _ O
data -X- _ O
demonstrate -X- _ O
that -X- _ O
modulation -X- _ O
of -X- _ O
APN -X- _ O
expression -X- _ O
by -X- _ O
metalloprotease -X- _ O
ADAM17 -X- _ O
regulates -X- _ O
PEDV -X- _ O
infection. -X- _ O
Hence -X- _ O
, -X- _ O
the -X- _ O
reduction -X- _ O
in -X- _ O
APN -X- _ O
expression -X- _ O
represents -X- _ O
another -X- _ O
component -X- _ O
of -X- _ O
the -X- _ O
anti-PEDV -X- _ O
infection -X- _ O
response -X- _ O
initiated -X- _ O
by -X- _ O
ADAM17 -X- _ O
. -X- _ O

